Bluetongue is a disease of ruminants. The etiologic agent is bluetongue virus (BTV), a gnat-transmitted member of the Orbivirus genus of the Reoviridae. The virus has a genome of 10 double-stranded RNA species Li to L3, M4 to M6, S7 to S10). The L2 and M5 genes of BTV which encode the outer capsid proteins VP2 and VP5, respectively, were inserted into a recombinant baculovirus downstream of duplicated copies of the baculovirus polyhedrin promoter. Insect cells coinfected with this virus plus a recombinant baculovirus expressing the two major core proteins VP3 and VP7 of BTV (T. J. French and P. Roy, J. Virol. 64:1530-1536, 1990) synthesized noninfectious, double-shelled, viruslike particles. When purified, these particles were found to have the same size and appearance as authentic BTV virions and exhibited high levels of hemagglutination activity. Antibodies raised to the expressed particles contained high titers of neutralizing activity against the homologous BTV serotype. The assembly of these bluetongue viruslike particles after the simultaneous expression of four separate proteins is indicative of the potential of this technology for the production of a new generation of viral vaccines and for the study of complex, multiprotein structures.
Gene cloning and expression have proved to be powerful tools for assessing the structural and/or functional roles of individual proteins. The natural progression for future studies will be the examination of multiprotein structures such as viruses or enzyme complexes. The assembly of viruslike particles (VLPs) after the synthesis of their component proteins is an area which presents a number of opportunities. For example, the stages of viral assembly, the contributions of individual components to that process, and the sites and nature of viral protein interactions can be studied. An increased understanding of viral morphogenesis may aid the development of antiviral agents which specifically interfere with the assembly process. Intact VLPs could also prove useful as vaccines if epitopes are presented in authentic conformations.
To date, only single-shelled VLPs or cores have been assembled after the expression of one (11, 16) or two (3) viral genes. For viruses with structures derived from the translation products of more than one mRNA, coexpression of different genes is required if essentially complete, albeit empty, particles are to be assembled. With such an objective in mind, baculovirus multiple expression vectors have been developed (2) . One such vector, pAcVC3, contains duplicated copies of the polyhedrin transcriptional machinery from Autographa californica nuclear polyhedrosis virus (AcNPV). This enables a recombinant baculovirus to be constructed which will express two foreign polypeptides simultaneously in Spodopterafrugiperda insect cells (3, 16) .
Bluetongue virus (BTV) is a member of the Orbivirus genus in the family Reoviridae. It is an arthropod-borne virus that causes disease in sheep and cattle. It has a genome consisting of 10 segments of double-stranded RNA (Li to L3, M4 to M6, S7 to S10) that are located in a core particle consisting of two major proteins (VP3 and VP7) and three * Corresponding author. minor proteins (VP1, VP4, and VP6). In intact virus, an outer capsid of two major proteins (VP2 and VP5) surrounds the core. Three nonstructural proteins are synthesized in BTV-infected cells. Their functions are unknown.
We have previously described the construction of a dual recombinant baculovirus that expresses both VP3 and VP7 and shown that empty corelike particles (CLPs) are assembled in insect cells infected with this recombinant virus (3) . When used to immunize animals, these single-shelled CLPs do not protect against subsequent BTV infection because the epitopes that elicit neutralizing antibodies are present on the outer capsid protein VP2 (4) (5) (6) . Since a recombinant baculovirus expressing VP2 has been constructed (6), we initially undertook coinfection experiments with the VP3 and VP7 dual vector 85 ,000 x g for 3 h. The particles were analyzed by SDS-PAGE (as above) or were examined by electron microscopy. BTV particles were purified from monolayers of BHK-21 cells infected with BTV serotype 10 as described previously (10) .
Western immunoblot analysis. Proteins were separated by SDS-PAGE and electroblotted onto Immobilon (Millipore Corp., Bedford, Mass.) with a Sartorius semi-dry electroblotter. The filter was soaked overnight at 4°C in blocking buffer (5% skim milk, 0.05% Tween 20 in phosphate-buffered saline) and then rabbit anti-BTV-10 serum (1:1,000 dilution in fresh blocking buffer) was added and the filter was gently agitated for 90 min at room temperature. After being washed for 1 h (0.05% Tween 20 in phosphate-buffered saline), the filter was returned to blocking buffer containing a 1:1,000 dilution of goat anti-rabbit immunoglobulin G (Sigma) and gently agitated at room temperature for 90 min. The filter was then washed again and placed in substrate (P-naphthyl phosphate disodium, fast blue BB salt, MgSO4) for 5 min before rinsing in water and drying. Since VP2 comigrates with VP3, its presence in the purified double-shelled VLPs and authentic BTV virions was confirmed by repeating the above protocol but reacting the filter with antiserum raised to expressed VP2 (6) .
Electron microscopy. Purified BTV-10 virions and expressed double-shelled VLPs were absorbed onto copper 400-mesh Formvar carbon-coated grids by floating the grids on droplets of the material for 2 min. After being washed twice in 0.2 M Tris hydrochloride (pH 8.0), the particles were stained for 20 s on droplets of 2% uranyl acetate. All grids were examined in a JEOL electron microscope.
Preparation of antibodies against VLPs, CLPs, and baculovirus-expressed BTV proteins. The VLPs and CLPs were purified as described above, and approximately 75 pLg of each material was injected intraperitoneally into guinea pigs at days 0, 7, 14, and 21. For anti-VP2 serum, infected S. frugiperda cell lysates containing VP2 protein were prepared as described previously (9) . Guinea pigs were similarly injected four times, each inoculum containing approximately 50 ,ug of VP2 protein. Serum samples were collected at day 31 by cardiac puncture from anesthetized guinea pigs. Preparation of rabbit antisera to VP2 or VP7 and mouse antisera to VP3 or VP5 has been described previously (6, 9) .
Neutralization and hemagglutination activity of antisera raised to expressed particles. Guinea pig antisera raised to expressed CLPs or VLPs or antisera raised to other BTV proteins were assayed for their neutralizing activity against BTV-10 in a plaque reduction test. A total of 200 PFU of BTV-10 were incubated with serial dilutions of antisera (in phosphate-buffered saline) at 37°C for 1 h before inoculating monolayers of BHK cells. After virus absorption at room temperature for 1 h, the inoculum was discarded and replaced with medium containing 0.8% agarose. After incubation for 3 days at 37°C, the plaques were visualized by applying a neutral red stain overlay.
Hemagglutination tests were performed in microtiter plates as described by Van Der Walt (18) . Serial dilutions of the purified particles were produced with TSAG buffer (10 mM Tris chloride [pH 9 .0], 140 mM NaCl, 1 mM CaCl2, 0.2% [wt/vol] bovine serum albumin fraction V). Erythro-cytes from rabbits were washed with Alsevier solution and then diluted with TSAG to produce a 0.25% suspension. A 50-pul portion of this suspension was added to each serial dilution and left overnight at 4°C. One HA unit is defined as the highest dilution at which hemagglutination occurs. The antisera to be tested as inhibitors were diluted serially with TSAG. Four HA units of the purified particles in a 25-,ul total volume of TSAG were then added to each well and left overnight at 4°C. Erythrocytes (50 [lI of a 0.25% suspension)
were then added, and the mixture was left overnight at 4°C. RESULTS Construction of dual recombinant baculovirus. cDNA copies representing the complete coding sequences of the BTV L2 and M5 genes were manipulated for expression in the baculovirus system as described in Materials and Methods (Fig. 1) . Recombinant baculoviruses were prepared by the established procedure of cotransfecting S. frugiperda insect cells with the recombinant plasmid DNA and wild-type AcNPV DNA (15) . Progeny viruses were titrated by using confluent monolayers of S. frugiperda cells, and putative recombinants were selected on the basis of their polyhedrinnegative phenotype (ca. 0.1% frequency). After successive rounds of plaque purification, a high-titered viral stock was prepared.
Coexpression of VP2 and VP5 in S. frugiperda cells. S. frugiperda cells infected with the recombinant baculovirus synthesized two unique protein species in place of the 29-kilodalton polyhedrin protein seen in wild-type AcNPVinfected cells (Fig. 2A) . The sizes of the expressed proteins agree with those expected for VP2 and VP5 calculated from their amino acid compositions (i.e., 111.1 and 59.1 kilodaltons, respectively [12, 13] ). Since the levels of expression were below that which could be determined by staining, confirmation that the expressed proteins represented authentic BTV proteins was provided by Western immunoblot analyses with antiserum raised to BTV-10 virus particles (Fig. 2B ). This antiserum reacted well with the VP2 and VP5 species in a cell lysate of S. frugiperda cells infected with the dual recombinant baculovirus. No reaction was detected with mock-infected or wild-type AcNPV-infected cells. BTV-10 virus particles were included as a control, from which it can be seen that the BTV-10 antisera also contained antibodies to the minor core protein VP6 (but not to VP1 or VP4).
Although the outer capsid of BTV is composed solely of VP2 and VP5, no capsidlike structures were detected in insect cells infected with the VP2-VP5 recombinant baculovirus. The absence of VP2-VP5 complexes in the infected insect cells was further confirmed by examination of immunoprecipitates of the infected cells with monospecific antisera to VP2 or VP5. Each antiserum precipitated only one protein, either VP2 or VP5 (data not shown), indicating that the VP2 and VP5 proteins were not present as complexes in the insect cells.
To assess the interaction of VP2 and VP5 with the BTV CLPs, insect cells were coinfected with both dual recombinant baculoviruses (to coexpress VP2, VP3, VP5, and VP7). The cells were harvested at 48 h postinfection and lysed with the nonionic detergent Nonidet P-40, and the released particles were purified to homogeneity by centrifugation on discontinuous sucrose gradients. When examined under the electron microscope, empty double-shelled particles were observed consisting of a core surrounded by a thick outer capsid (Fig. 3A, large arrows) . The -"-VP3 particles were estimated to be of the order of 85 nm, i.e., comparable to those of BTV (Fig. 3B) . Some simple CLPs were also observed in the preparation (Fig. 3A, thin a HA titers are expressed as the reciprocal of the highest serial dilution that gave complete hemagglutination. Antisera raised to the particles and baculovirus-expressed BTV proteins were used in hemagglutination inhibition (HI) and plaque reduction neutralization tests. The inhibition titers are expressed as the reciprocal of the highest serial dilution of the serum that gave complete inhibition of hemagglutination. The plaque reduction neutralization titers are expressed as the reciprocal of the serum dilution that gave a 50% reduction in plaque numbers. Guinea pig (GP), rabbit, and mouse sera were used as indicated.
that VP2 is the hemagglutinating protein of BTV (18) . Monospecific serum raised to VP2 inhibited hemagglutination by the VLPs. Monospecific sera raised to the other component proteins (VP3, VP5, or VP7) had essentially no effect (Table 1) . Unlike authentic BTV, the VLPs were noninfectious when assayed in mammalian cells. DISCUSSION BTV cores are composed of two major and three minor proteins in addition to the 10 segments of double-stranded RNA. An outer capsid of two major proteins surrounds the core. Coexpression of the two major core proteins (VP3 and VP7) in insect cells by a multiple recombinant baculovirus results in the synthesis of CLPs of the same size, appearance, and stoichiometric arrangement of VP3 to VP7 as authentic BTV core particles (3). Attempts to attach the outer capsid proteins (VP2 and VP5) individually to these CLPs by coinfecting insect cells with the VP3-VP7 dual recombinant and either a recombinant expressing VP2 or one expressing VP5 were unsuccessful. A second dual recombinant expressing both VP2 and VP5 simultaneously was therefore constructed. Unlike the two core proteins, this dual recombinant virus failed to form any capsid or VP2-VP5 complex in the insect cells. It is likely that the two proteins need the core structure before they can interact. When insect cells were coinfected with the VP2-VP5 recombinant plus the VP3-VP7 recombinant, empty double-shelled VLPs were assembled. The formation of these particles leads to several interesting conclusions regarding BTV morphogenesis. The failure of VP2 and VP5 to attach individually to the cores suggests that the interaction of these proteins occurs during the process of assembly of VLPs. As with the formation of CLPs in insect cells, the addition of the outer capsid is not dependent on the presence of the BTV nonstructural proteins (NS1, NS2, NS3), or viral doublestranded RNA, or the minor proteins VP1, VP4, and VP6. 
